ROS vides at begrænse den antileukæmiske virkning af lymfocyt- aktivatorer som IL- 2 ved at udløse dysfunktion og død ved apoptose i NK- celler og T- celler.
ROS are known to limit the anti-leukaemic effects of lymphocyte activators such as IL-2, by triggering dysfunction and death by apoptosis in NK cells and T cells.